IceCure

The company IPOed in 2011

GizaVC invests in the vision of Israel's most innovative entrepreneurs.

About

IceCure Medical develops innovative, minimally invasive products for the treatment of breast tumors and other internal diseased tissue. It focuses on benign (non-cancerous) tumors, especially fibroadenoma in the women’s health space. Treatment is based on disruptive cryosurgery technology, which is reliable and safe and saves surgical, hospitalization, recovery and rehabilitation costs.